195 related articles for article (PubMed ID: 33099283)
1. Long-Term Antithrombotic Treatments Prescribed for Cardiovascular Diseases in Patients with Hemophilia: Results from the French Registry.
Guillet B; Cayla G; Lebreton A; Trillot N; Wibaut B; Falaise C; Castet S; Gautier P; Claeyssens S; Schved JF
Thromb Haemost; 2021 Mar; 121(3):287-296. PubMed ID: 33099283
[TBL] [Abstract][Full Text] [Related]
2. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF.
Verheugt FWA; Ambrosio G; Atar D; Bassand JP; Camm AJ; Costabel JP; Fitzmaurice DA; Illingworth L; Goldhaber SZ; Goto S; Haas S; Jansky P; Kayani G; Stepinska J; Turpie AGG; van Eickels M; Kakkar AK;
Am J Med; 2019 Dec; 132(12):1431-1440.e7. PubMed ID: 31306621
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
Windecker S; Lopes RD; Massaro T; Jones-Burton C; Granger CB; Aronson R; Heizer G; Goodman SG; Darius H; Jones WS; Aschermann M; Brieger D; Cura F; Engstrøm T; Fridrich V; Halvorsen S; Huber K; Kang HJ; Leiva-Pons JL; Lewis BS; Malaga G; Meneveau N; Merkely B; Milicic D; Morais J; Potpara TS; Raev D; Sabaté M; de Waha-Thiele S; Welsh RC; Xavier D; Mehran R; Alexander JH;
Circulation; 2019 Dec; 140(23):1921-1932. PubMed ID: 31557056
[TBL] [Abstract][Full Text] [Related]
4. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
[TBL] [Abstract][Full Text] [Related]
5. Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: "OLTAT registry".
Fischer Q; Georges JL; Le Feuvre C; Sharma A; Hammoudi N; Berman E; Cohen S; Jolivet I; Silvain J; Helft G
Int J Cardiol; 2018 Aug; 264():64-69. PubMed ID: 29776575
[TBL] [Abstract][Full Text] [Related]
6. Management of antithrombotic therapy for acute coronary syndromes and atrial fibrillation in patients with hemophilia.
Mannucci PM
Expert Opin Pharmacother; 2012 Mar; 13(4):505-10. PubMed ID: 22332913
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
[TBL] [Abstract][Full Text] [Related]
8. Bleeding Events Before Coronary Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.
Redfors B; Kirtane AJ; Pocock SJ; Ayele GM; Deliargyris EN; Mehran R; Stone GW; Généreux P
J Am Coll Cardiol; 2016 Dec; 68(24):2608-2618. PubMed ID: 27978944
[TBL] [Abstract][Full Text] [Related]
9. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
[TBL] [Abstract][Full Text] [Related]
10. Performance of HAS-BLED, ORBIT, PRECISE-DAPT, and PARIS risk score for predicting long-term bleeding events in patients taking an oral anticoagulant undergoing percutaneous coronary intervention.
Yoshida R; Ishii H; Morishima I; Tanaka A; Morita Y; Takagi K; Yoshioka N; Hirayama K; Iwakawa N; Tashiro H; Kojima H; Mitsuda T; Hitora Y; Furusawa K; Tsuboi H; Murohara T
J Cardiol; 2019 Jun; 73(6):479-487. PubMed ID: 30598387
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry.
Corbalan R; Bassand JP; Illingworth L; Ambrosio G; Camm AJ; Fitzmaurice DA; Fox KAA; Goldhaber SZ; Goto S; Haas S; Kayani G; Mantovani LG; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Kakkar AK;
JAMA Cardiol; 2019 Jun; 4(6):526-548. PubMed ID: 31066873
[TBL] [Abstract][Full Text] [Related]
12. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic therapy and outcomes after ICD implantation in patients with atrial fibrillation and coronary artery disease: an analysis from the National Cardiovascular Data Registry (NCDR)®.
Ghanbari H; Nallamothu BK; Wang Y; Curtis JP
J Am Heart Assoc; 2015 Jan; 4(2):. PubMed ID: 25637345
[TBL] [Abstract][Full Text] [Related]
14. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
[TBL] [Abstract][Full Text] [Related]
15. Phase 4 Safety and Efficacy Study of Antihemophilic Factor (Recombinant) in Previously Treated Chinese Patients With Severe/Moderately Severe Hemophilia A.
Zhao Y; Hu Y; Jin J; Zhao X; Wang X; Wu R; Wu D; Yang R; Yang F; Hu Q; Wang J; Fang H; Engl W
Clin Appl Thromb Hemost; 2021; 27():1076029621989811. PubMed ID: 33587652
[TBL] [Abstract][Full Text] [Related]
16. Edoxaban versus warfarin in patients with atrial fibrillation.
Giugliano RP; Ruff CT; Braunwald E; Murphy SA; Wiviott SD; Halperin JL; Waldo AL; Ezekowitz MD; Weitz JI; Špinar J; Ruzyllo W; Ruda M; Koretsune Y; Betcher J; Shi M; Grip LT; Patel SP; Patel I; Hanyok JJ; Mercuri M; Antman EM;
N Engl J Med; 2013 Nov; 369(22):2093-104. PubMed ID: 24251359
[TBL] [Abstract][Full Text] [Related]
17. [Anticoagulation status and adherence in patients with atrial fibrillation hospitalized for ACS and the impact on 1-year prognosis: a multicenter cohort study].
Zhu LY; Li Q; Yu LY; Liu Y; Chen YN; Wang Z; Zhang SY; Li J; Liu Y; Zhao YL; Xi Y; Pi L; Sun YH
Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jul; 51(7):731-741. PubMed ID: 37460427
[No Abstract] [Full Text] [Related]
18. Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry).
Mennuni MG; Halperin JL; Bansilal S; Schoos MM; Theodoropoulos KN; Meelu OA; Sartori S; Giacoppo D; Bernelli C; Moreno PR; Krishnan P; Baber U; Lucarelli C; Dangas GD; Sharma SK; Kini AS; Tamburino C; Chieffo A; Colombo A; Presbitero P; Mehran R
Am J Cardiol; 2015 Jul; 116(1):37-42. PubMed ID: 25956624
[TBL] [Abstract][Full Text] [Related]
19. Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry.
Le Heuzey JY; Bassand JP; Berneau JB; Cozzolino P; D'Angiolella L; Doucet B; Mantovani LG; Martelet M; Mouallem J; Muller JJ; Pieper K;
Arch Cardiovasc Dis; 2018 Dec; 111(12):749-757. PubMed ID: 29861295
[TBL] [Abstract][Full Text] [Related]
20. An analysis of antithrombotic therapy in elderly patients with atrial fibrillation undergoing percutaneous coronary interventions.
Zhou J; Wang X; Yu J; Wu Y; Li X; Xie X; Zhang X; Cheng D; Yang B
Clin Exp Pharmacol Physiol; 2023 Jul; 50(7):583-593. PubMed ID: 37057840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
